NCT04632238

Brief Summary

This project will develop and test quality measures for and a facilitation model to help addictions treatment clinics increase use of medicines for opioid use disorders, retain clients longer in care, and help more people move into successful recovery. At the end of the project, we will have developed specific training and coaching protocols as well as electronic clinical support tools to guide quality improvement that can be disseminated within New York and the rest of the country. The study will test a clinic-level intervention that uses external facilitators to provide guidance to addictions clinics and contain three key components: 1) training on data driven management; 2) training and guidance on patient-centered care and OUD medication; and 3) electronic tools for shared decision making and patient progress monitoring.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
7,950

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2020

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

November 12, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 17, 2020

Completed
4.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2025

Completed
Last Updated

October 29, 2025

Status Verified

October 1, 2025

Enrollment Period

5 years

First QC Date

November 12, 2020

Last Update Submit

October 28, 2025

Conditions

Outcome Measures

Primary Outcomes (7)

  • Change in clinic-level rates of initiation to OUD medications

    Assessed from commencement of the trial in Year 1 of the study to the conclusion of the trial in Year 4 of the study.

  • Change in clinic-level rates of adherence to OUD medications

    Assessed from commencement of the trial in Year 1 of the study to the conclusion of the trial in Year 4 of the study.

  • Retention in Care

    Clinic rates of 6-month client retention in care

    Assessed from commencement of the trial in Year 1 of the study to the conclusion of the trial in Year 4 of the study.

  • Change in Incidence of Overdoses

    Assessed from commencement of the trial in Year 1 of the study to the conclusion of the trial in Year 4 of the study.

  • Change in Incidence of Substance Use-Related Hepatitis C Infection

    Assessed from commencement of the trial in Year 1 of the study to the conclusion of the trial in Year 4 of the study.

  • Change in Number of Emergency Room Visits

    Assessed from commencement of the trial in Year 1 of the study to the conclusion of the trial in Year 4 of the study.

  • Change in Health Status

    Change in health status is measured by the first item of the SF-12 Health Survey: "In general, would you say your health is: 1 - excellent, 2 - very good, 3 - good, 4 - fair, 5 - poor". Scores range from 1-5, with a higher score indicating worse health.

    Assessed from the start of each clinic in the intervention to 1 year post-intervention

Secondary Outcomes (4)

  • Cost of treatment

    Assessed from commencement of the intervention at each clinic to 1 year post-intervention

  • Change in clinic-level rates of clients with Severe OUD

    Assessed from commencement of the intervention at each clinic to 1 year post-intervention

  • Change in clinic level-rates of clients identified as homeless

    Assessed from commencement of the intervention at each clinic to 1 year post-intervention

  • Change in clinic-rates of clients with co-existing psychiatric disorder as indicated in state administrative admission data

    Assessed from commencement of the intervention at each clinic to 1 year post-intervention

Study Arms (2)

Control

NO INTERVENTION

Metrics-driven quality improvement (MDQI) intervention

EXPERIMENTAL
Behavioral: Metrics-driven quality improvement (MDQI)

Interventions

The intervention broadly consists of training and coaching to clinic staff and leadership on 1) clinical quality measure monitoring; 2) clinical practice process change management; and 3) use of tools for shared decision making and patient treatment progress monitoring.

Metrics-driven quality improvement (MDQI) intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Substance use disorder clinics in the regions surrounding New York City and the New York Capital Region with annual census of 50 or greater.
  • All staff and patients from participating clinics will be eligible to participate in the study.

You may not qualify if:

  • Patients who are not working/being treated at substance use disorder clinics with less than 50 clients per year.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Samaritan Rockland - Outpatient Program

Blauvelt, New York, 10913, United States

Location

Samaritan Queens - Jamaica IOP

Jamaica, New York, 11435, United States

Location

Samaritan Daytop Village Harlem - Outpatient Program

New York, New York, 10027, United States

Location

Upper Manhattan Addiction Treatment Services Program

New York, New York, 10031, United States

Location

Related Publications (1)

  • O'Grady MA, Lincourt P, Greenfield B, Manseau MW, Hussain S, Genece KG, Neighbors CJ. A facilitation model for implementing quality improvement practices to enhance outpatient substance use disorder treatment outcomes: a stepped-wedge randomized controlled trial study protocol. Implement Sci. 2021 Jan 7;16(1):5. doi: 10.1186/s13012-020-01076-x.

MeSH Terms

Conditions

Opioid-Related DisordersSubstance-Related Disorders

Condition Hierarchy (Ancestors)

Narcotic-Related DisordersChemically-Induced DisordersMental Disorders

Study Officials

  • Charles Neighbors, PhD

    NYU Langone Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SEQUENTIAL
Model Details: Stepped Wedge Cluster Randomized Trial (SW-RCT)
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 12, 2020

First Posted

November 17, 2020

Study Start

July 1, 2020

Primary Completion

June 30, 2025

Study Completion

June 30, 2025

Last Updated

October 29, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will share

Individual participant data that underlie the results reported in this article resulting from surveys only, after deidentification (text, tables, figures, and appendices), will be available. Client outcome data from State administrative data files will not be available for sharing due to the nature of the data security agreements.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research.
Access Criteria
The investigator who proposed to use the data upon reasonable request. Requests should be directed to Charles.Neighbors@nyulangone.org. To gain access, data requestors will need to sign a data access agreement.

Locations